StockWatch
·

Network People Services Technologies Ltd Q2 FY27 Results

NPSTQ2 FY27 Results
Filing
Result:Steady· Market: Down#Margin squeeze#Base effect

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue67.7419.9%45.1%
Total Income72.9518.8%49.9%
Expenditure56.0119.4%59.2%
PBT16.9416.9%25.6%
Net Profit13.2219.6%34.3%
OPM23.60%0.92pp5.63pp
NPM18.12%0.13pp2.11pp
EPS6.3420.5%26.8%
View full financials

IT/services lens: revenue growth is strong at +45.1% YoY but the core profitability signal — EBIT/operating margin — compressed to 23.2% from 29.2% YoY and PAT growth trailed revenue growth, while the print also fell short of management's own FY27 guidance (60-70% revenue growth, 30% EBITDA margin), making this an in-line-to-soft quarter despite the headline growth.

NPST · Q2 FY27 · THE VERDICT

Growth delivered, margins stumble, and the H2 bet is real

Revenue grew 45% YoY and the company signed two landmark deals—but operating margins fell to 23.6% from a 30% prior target. Q2 is solid; the FY27 guidance depends entirely on flawless H2 execution on deals not yet generating revenue.

16 Nov 2026 · 6 min read
Revenue

₹67.7 Cr

Q2 FY27, +45% YoY

Net Profit

₹13.2 Cr

+34% YoY, +19.6% QoQ

Op. Margin

23.6%

vs ₹30% prior target

TSP mix

80–85%

up from 20%, lower initial margins

Network People delivered on the topline in Q2: 45% revenue growth and 34% profit growth look clean on the scoreboard. The company also signed two of its largest deals on record—a multi-year Sri Lanka telecom contract with execution starting Q4, and a LOI for a 300+ Indian bank bank-in-a-box platform. But underneath that headline lies the real story. Operating margin slipped to 23.6% from a prior 30% target, and management has quietly conceded the FY27 guidance—₹320–340 Cr revenue—will only land if H2 delivers 45–60% sequential growth on deals that haven't started executing yet. That's the genuine tension of the quarter: growth is here, but the path to the full-year target requires everything to go right in the next nine months.

Where the numbers came from

Q2 revenue of ₹67.7 Cr grew 45.1% YoY, but management had claimed 72.95 Cr in opening remarks—a ₹5.25 Cr gap (7.2% overstatement). That gap flags either aggressive accounting on standalone figures or loose real-time reporting, worth tracking in future calls. PAT of ₹13.2 Cr at 34.3% YoY growth checked out, with NPM holding steady at 18.1%. Profit growth outpacing revenue growth suggests cost leverage from the business mix shift or one-time benefits, but it came packaged with the margin hit: operating margin compressed to 23.6% from the prior 30% EBITDA target.

The margin miss is structural, not a timing blip. The TSP (telecom service provider) segment jumped from 20% of revenue two years ago to 80–85% of Q2 revenue today—a deliberate pivot from licensing and professional services (higher margin, slower growth) to bundled, recurring payment infrastructure contracts (lower upfront margin, steadier cash flow). Management has signalled margin recovery to 25–28% next year as international SaaS scales, but the 30% target for FY27 is off the table. EBITDA at ~₹16 Cr (implied) was up 17% YoY, confirming the growth; the pressure is on margin percentage, not absolute profit.

Management's claims vs. what holds up

Key assertions from the call graded against the delivered results

Q2 revenue 72.95 Cr, ~50% YoY growth

What the numbers show

67.7 Cr delivered at 45.1% YoY (₹5.25 Cr gap)

Verdict

Overstated by 7.2%

EBITDA 16 Cr, steady margin contribution

What the numbers show

~16 Cr at 23.6% OPM (margin confirmed lower than prior target)

Verdict

Supported, but FY27 target missed

PAT 13.21 Cr, 34% YoY growth

What the numbers show

13.2 Cr at 34.3% YoY (exact match)

Verdict

Supported

FY27 ₹320–340 Cr on 60–70% growth

What the numbers show

H1 ~₹124 Cr requires H2 of ₹196–216 Cr (45–60% sequential gain)

Verdict

Achievable but aggressive; entirely dependent on deal execution

30% EBITDA margins to be maintained in FY27

What the numbers show

Q2 at 23.6% OPM; management now says gradual recovery to 25–28% next year

Verdict

Contradicted; target will be missed this year

What changed on this call

  • TSP mix doubled to 80–85% from 20%, signalling complete pivot from licensing to recurring SaaS-like contracts

  • Two marquee deals announced: Sri Lanka's largest telecom provider (5-year, multi-million dollar) and 300+ Indian banks (10-digit value, 18–24 month execution window)

  • International funnel upgraded from 10 countries in discussion to 5–15 live RFPs, anchored by largest global telecom provider signature

  • Unnamed acquisition in progress (cost not finalized, deal not yet closed; will disclose upon close)

  • Margin guidance downgrade de facto: 30% FY27 target now conceded as unachievable; recovery promised at 25–28% next year ('gradual')

The bull case vs. the bear case

Risks, ranked by concern to a holder

What could go wrong, sorted by severity and near-term impact

Deal execution delays (Sri Lanka, 300+ bank, 5–15 intl RFPs slip beyond H2)

High

FY27 ₹320–340 Cr target depends entirely on new deals executing in H2. Any deferral to FY28 triggers full-year guidance reset, re-rating downside, and pushes margin recovery timeline right.

Margin recovery extends beyond next year (25–28% target misses)

High

TSP mix at 80–85% with lower initial margins is structural. If international SaaS-ification and customer mix transition take longer than expected, margins stay depressed, hurting multiple compression.

Deal conversion slippage (Sri Lanka 9-month execution, 300+ bank 18–24 months, high concentration risk)

High

Both deals LOI stage, not signed. Long customer onboarding cycles and potential churn on execution issues could cascade. 300+ bank deal represents concentration risk (single customer, 10-digit value).

Regulatory uncertainty on MDR cap, DPDP, HSM adoption (timelines, impact unquantified)

Medium

Management deferred specifics; new regulatory changes could be tailwinds (compliance tools) or headwinds (pricing pressure) depending on bank adoption pace. Q3–Q4 clarity critical.

International expansion execution complexity (localization, partnerships, regulatory approvals across 10+ countries)

Medium

First time at scale outside India. Track record unknown. Could delay 5–15 pipeline conversion and extend margin recovery. SaaS model lower margin initially adds cycle risk.

Unnamed acquisition integration (cost not finalized, structure opaque, return on capital unknown)

Medium

High valuation or integration issues could materially impact FY27–28 margins, cash position, and distract management from core deal execution.

How the street is positioned

The stock closed at ₹1711.4 on Nov 16, trading neutral (RSI 48) with volume trending higher. It's consolidating around the 20-day moving average (₹1706.22) but below the 50-day MA (₹1747), a picture of neither breakdown nor breakout. The 52-week range is ₹846.6–₹1930.2, and the stock is down 52% from its all-time high of ₹3577—a substantial drawdown that signals the market has already baked in execution concerns and is either waiting for proof or pricing in a miss. The low price is not a screaming buy signal; it reflects fear on deal execution.

Ownership is tilted domestic and founder-heavy. Promoters hold 60.48% (unchanged QoQ), DIIs account for 10.39% (up 0.37pp from Q1), and FIIs are negligible at 0.32% (up 0.24pp but still near zero). The lack of foreign institutional conviction despite a credible long-term thesis (₹850–900 Cr target) suggests either scepticism on India payment-infra execution or the stock's small float and liquidity constraints pricing them out. DII steadiness indicates domestic institutional support, likely anchored to the multi-year SaaS and international bet. The FII absence is notable; usually a sign that large foreigners are watching but not committed until execution is proven.

No insider selling signals. Bulk deal activity from early September (JUNOMONETA and MICROCURVES trading at ₹1846–1859) was immaterial. No promoter or insider-linked selling near current levels or the all-time high; the share structure has been stable for quarters. That's neither a bull nor a bear flag—it's neutral, suggesting founders are not signalling distress or confidence via the market, just waiting for H2 execution.

The technical setup is choppy: the stock is holding support at the 20-day MA but has not broken above the 50-day in recent weeks. For a small-cap with three execution bets, the lack of FII conviction and the dull technicals suggest the market is in wait-and-see mode. Domestic flows will likely drive the narrative. H2 Q3–Q4 results on deal traction and margin trajectory will either ignite the stock or trigger another leg down.

What to watch next

  • 1 · H2 FY27 deal revenue contribution and execution milestones (Q3 onwards)

    Sri Lanka Telecom ramp-up (execution Q4 start), 300+ bank bank-in-a-box first revenue (Q4 start, 18–24 month cycle), and 5–15 international RFP conversions (Q3–Q4 expected). Any material delay or missed milestone triggers guidance reset and re-rating downside. Watch for: customer onboarding pace, integration complexity, and revenue recognition timing.

  • 2 · Operating margin trajectory and SaaS mix recovery (Q3 FY27 onwards)

    Will OPM stabilize at 25–28% by Q3–Q4 as management promised, or compress further due to new customer acquisition headwinds? If margins worsen QoQ, the 25–28% recovery target becomes less credible, and the long-term 35%+ EBITDA target becomes a stretch. Watch for: cost structure changes, SaaS revenue %, and per-customer unit economics.

  • 3 · Unnamed acquisition close and integration plan (Q4 FY27–Q1 FY28)

    Deal cost, structure, and integration timeline. High acquisition valuation or management distraction during integration could impact FY28 margins and cash position. Watch for: announcement details, integration roadmap, and synergy realization timeline.

The number to track

H2 FY27 operating margin. The company needs ₹196–216 Cr revenue in H2 to hit the ₹320–340 Cr full-year target; that will be monitored closely. But the margin trajectory is the real proof point: if Q3–Q4 operating margins stay below 24%, the SaaS transition and international ramp are not delivering the uplift management promised, and the 25–28% next-year target becomes less believable. If H2 OPM is at or above 24%, the transition is working, and the long-term 35%+ thesis gains credibility. Operating margin is the bridge between near-term execution (will deals ramp on schedule?) and long-term credibility (is the SaaS play real?). Track it obsessively in Q3 and Q4.

NPST's Q2 is a solid stepping stone, not a breakthrough. Revenue growth is real, the deal pipeline is concrete with named customers and timelines, and the long-term vision (₹850–900 Cr at 35%+ margins by FY29) is credible on paper. But the company is asking holders to endure near-term margin headwinds (23.6% vs 30% target) and bet on flawless execution on three fronts in H2 FY27. The stock's 52% drawdown from its all-time high and minimal foreign institutional interest (0.32% FII) reflect that bet being priced in—or feared. The next 9 months will prove or disprove the thesis. Until H2 results are in, Hold is the honest call: the upside on deal delivery is real, and so is the execution risk.

This is a transition quarter. The company is pivoting from a licensing and professional services model (high margin, slow growth) to recurring SaaS and international payment infrastructure (lower upfront margin, faster growth, higher upside). That's the right move for a ₹850–900 Cr vision, but it comes with visible near-term cost in margins and invisible cost in execution risk. Watch H2 closely. The deal sheet is impressive; the execution risk is real. Both matter.

Informational and educational content only. Not investment advice.